Circulatory assistance in acute heart failure where do we go from here?

Scandinavian Cardiovascular Journal

Volumn 43, Issue 4, 2009, Pages 211-216

  Hermansen, Stig E ^a,b   Næsheim, Torvind ^a   How, Ole Jakob ^b   Myrmel, Truls ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AXIAL FLOW RECOVERY SYSTEM; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECTRA CORPOREAL MEMBRANE OXYGENATION; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; EVIDENCE BASED MEDICINE; EXTRACORPOREAL OXYGENATION; HEART SURGERY; INSTRUMENTATION; MORTALITY; NOTE; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ACUTE DISEASE; CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 70349579138     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430802715962     Document Type: Review

References (48)

1. Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, van der Werf F, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA. 2007;/297:/1657-66.
2. Moses LE. The series of consecutive cases as a device for assessing outcome of interventions. In: Bailar JC III, Mosteller F, editors. Medical uses of statistics, 2nd ed. Boston, MA: NEJM Books; 2000. p. 125-141
3. Linden H, Wiklund L, Haraldsson A° , Berglin E, Hultman J, Dellgran G. Temporary circulatory support with ECMO in adults with refractory cardiogenic shock. Scand Cardiovasc J. 2009 (this issue).
4. Granfeldt H, Hellgren L, Dellgren G, Myrdal G,Wassberg G, Kjellman U, et al. The Impella† recovery axial-flow system for acute heart failure at three cardiothoracic centers in Sweden. Scand Cardiovasc J. 2009 (this issue).
5. Bartlett RH, Gazzaniga AB, Fong SW, Jefferies MR, Roohk HV, Haiduc N. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. J Thorac Cardiovasc Surg. 1977;/73:/375-86.
6. UK Collaborative ECMO Trail Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet. 1996;/348:/75-82.
7. Chaturvedi RR, Macrae D, Brown KL, Schindler M, Smith EC, Davis KB, et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery. Heart. 2004;/90:/545-51.
8. Thourani VH, Kirshbom PM, Kanter KR, Simsic J, Kogon BE, Wagoner BE, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann Thorac Surg. 2006;/82:/138-44.
9. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;/242:/2193-6.
10. Morris AH,Wallace CJ, Menlove RL, Clemmer TP, Orme JF, Weaver LK, et al. Randomized clinical trial of pressurecontrolled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;/149:/295-305.
11. Nichol G, Karmy-Jones R, Salerno C, Cantore L, Becker L. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation. 2006;/70:/381-94.
12. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: Survival at five years. J Thorac Cardiovasc Surg. 2001;/122:/92-102.
13. Chen JS, Ko WJ, Yu HY, Lai LP, Huang SC, Chi NH, et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med. 2006;/34:/950-7.
14. Doll N, Fabricius A, Borger MA, Bucerices J, Kramer K, Doll S, et al. Temporary extracorporeal membrane oxygenation in patients with refractory postoperative cardiogenic shock-a single center experience. J Card Surg. 2003;/18:/512-8.
15. Doll N, Kiaii B, Borger M, Bucerices J, Kramer K, Schmitt DV, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004;/ 77:/151-7. (Pubitemid 38130002)
16. Chen YS, Lin JW, Yu HY, Ko WJ, Jeng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: An observational study and propensity analysis. Lancet. 2008;/372:/554-61.
17. Hoefer D, Ruttmann E, Poelzl G, Kilo J, Hoermann C, Margreiter R, et al. Outcome evaluation of the bridge-tobridge concept in patients with cardiogenic shock. Ann Thorac Surg. 2006;/82:/28-33.
18. Taghavi S, Zuckermann A, Ankersmit J, Wieselhaker G, Rajek A, Laufer G, et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg. 2004;/78:/1644-9.
19. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;/26:/1276-83.
20. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;/152:/469-8.
21. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac Cardiovasc Surg. 2003;/51:/312-7.
22. Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004;/77:/ 1642-1647
23. Garatti A, Colombo T, Russo C, Lanfranconi M, Milazzo F, Catena E, et al. Left ventricular mechanical support with the Impella Recover left direct microaxial blood pump: A singlecenter experience. Artif Organs. 2006;/30:/523-8.
24. Seyfarth M, Sibbing D, Bauer I, Frolich G, Bott-Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;/52:/1584-8.
25. Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A, Olschewski M, et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: A three-center experience. J Thorac Cardiovasc Surg. 2004;/127:/812-22.
26. Merhige ME, Smalling RW, Cassidy D, Barrett R, Wise G, Short J, et al. Effect of the hemopump left ventricular assist device on regional myocardial perfusion and function. Reduction of ischemia during coronary occlusion. Circulation. 1989;/80:/158-66.
27. Baldwin RT, Radovancevic B, Conger JL, Matsunaka R, Duncan JM, Vaughn WK, et al. Peripheral organ perfusion augmentation during left ventricular failure. A controlled bovine comparison between the intraaortic balloon pump and the Hemopump. Tex Heart Inst J. 1993;/20:/275-80.
28. Smalling RW, Cassidy DB, Barrett R, Lachterman B, Felli P, Amirian J. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation. 1992;/85:/1152-9.
29. Scholz KH, Hering JP, Schroder T, Uhlig P, Kreuzer H, Hellige G. Left-ventricular unloading by transvalvular axial flow pumping in experimental cardiogenic shock and during regional myocardial ischemia. Cardiology. 1994;/84:/202-10.
30. Sauren LD, Accord RE, Hamzeh K, de Jong M, van der Nagel T, van der Veen FH, et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: An experimental study. Artif Organs. 2007;/31:/ 839-842
31. Marks JD, Pantalos GM, Long JW, Kinoshita M, Everett SD, Olsen DB. Myocardial mechanics, energetics, and hemodynamics during intraaortic balloon and transvalvular axial flow hemopump support with a bovine model of ischemic cardiac dysfunction. ASAIO J. 1999;/45:/602-9.
32. Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: Experience with the Abiomed BVS system. J Card Surg. 1999;/14:/288-93.
33. Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, et al. Prognosis after the implantation of an intraaortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002;/106:/203-6.
34. Samuels LE, Holmes EC, Thomas MP, Entwistle JC, Morris RJ, Narula J, et al. Management of acute cardiac failure with mechanical assist: Experience with the ABIOMED BVS 5000. Ann Thorac Surg. 2001;/71:/67-72.
35. Jeger RV, Lowe AM, Buller CE, Pfisterer ME, Dzavik V, Webb JG, et al. Hemodynamic parameters are prognostically important in cardiogenic shock but similar following earlyrevascularization or initial medical stabilization: A report from the SHOCK trial Chest. 2007;/132:/1794-803.
36. Potapov EV, Loforte A, Weng Y, Jurmann M, Pasic M, Drew ST, et al. Experience with over 1000 implanted ventricular assist devices. J Card Surg. 2008;/3:/185-94.
37. Felker GM, Cotter G. Unraveling the pathophysiology of acute heart failure: An inflammatory proposal. Am Heart J. 2006;/151:/765-7.
38. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation. 2003;/ 107:/2998-3002.
39. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;/165:/1643-50.
40. Graulich J, Sonntag J, Marcinkowski M, Bauer K, Kossel H, Buhrer C, et al. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. 2002;/11:/69-73.
41. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;/86:/845-57.
42. Eikelboom JW, O'Donnell M. Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction. JAMA. 2007;/297:/91-2.
43. Testa L, Van Gaal WJ, Bhindi R, Biondi-Zoccai GG, Abbate A, Agostoni P, et al. Pexelizumab in ischemic heart disease: A systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg. 2008;/136:/884-93.
44. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003;/107:/ 3133-3140
45. Haverich A, Shernan SK, Levy JH, Chen JC, Carrier M, Taylor KM, et al. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. Ann Thorac Surg. 2006;/82:/486-92.
46. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, et al. Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004;/109:/1594-602.
47. Hermansen SE, Hansen M, Roaldsen M, Muller S, How OJ, Myrmel T. How many acute heart failure patients need a ventricular assist device? Scand Cardiovasc J. 2008;/42:/ 118-124
48. Bachet J. The potatoes and the bottle. Eur J Cardiothorac Surg. 2004;/25:/242-5.